The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Gehm, B. D., McAndrews, J. M., Chien, P.-Y., & Jameson, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14138 · Cited by 1,063
Caspases: the proteases of the apoptotic pathway
Nuñez, G., Benedict, M. A., Hu, Y., & Inohara, N. (1998) · Oncogene · doi:10.1038/sj.onc.1202581 · Cited by 1,046
Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2
Gimbrone, M. A., Cotran, R. S., Leapman, S. B., & Folkman, J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.413 · Cited by 758
Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control Studies
Howe, G. R., Hirohata, T., Hislop, T. G., Iscovich, J. M., Yuan, J.-M., Katsouyanni, K., Lubin, F., Marubini, E., Modan, B., Rohan, T., et al. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.7.561 · Cited by 750
Ovarian ablation in early breast cancer: overview of the randomised trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)05023-4 · Cited by 561
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Bowers, J. L., Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7721 · Cited by 526
Rose, D. P., Boyar, A. P., & Wynder, E. L. (1986) · Cancer · doi:10.1002/1097-0142(19861201)58:11<2363::aid-cncr2820581102>3.0.co;2-# · Cited by 518
Bachelder, R. E., Crago, A. M., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G. S., & Mercurio, A. M. (2001) · PubMed · Cited by 487
Dietary phytoestrogens and cancer: in vitro and in vivo studies
Adlercreutz, H., Mousavi, Y., Clark, J., Höckerstedt, K., Hämäläinen, E., Wähälä, K., Mäkelä, T., & Hase, T. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90359-q · Cited by 432
Cancer Chemopreventive Activity of Resveratrol
BHAT, K. P. L., & PEZZUTO, J. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 398
Yoshiji, H., Gomez, D. E., Shibuya, M., & Thorgeirsson, U. P. (1996) · PubMed · Cited by 369
Brown, L. F., Guidi, A. J., Schnitt, S. J., Water, L. V. D., Iruela‐Arispe, M. L., Yeo, T. K., Tognazzi, K., & Dvorak, H. F. (1999) · PubMed · Cited by 365
Lu, R., & Serrero, G. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199906)179:3<297::aid-jcp7>3.0.co;2-p · Cited by 334
Brâkenhielm, E., Cao, R., & Cao, Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0028fje · Cited by 334
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat, K., Lantvit, D. D., Christov, K. T., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (2001) · PubMed · Cited by 330
Antiproliferative effect of synthetic resveratrol on human breast epithelial cells.
Mgbonyebi, O. P., Russo, J., & Russo, I. H. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.4.865 · Cited by 275
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
Linderholm, B., Tavelin, B., Grankvist, K., & Henriksson, R. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3121 · Cited by 264
DNA Polymerase and Topoisomerase II Inhibitors from Psoraleacorylifolia
Sun, N. J., Woo, S. H., Cassady, J. M., & Snapka, R. M. (1998) · Journal of Natural Products · doi:10.1021/np970488q · Cited by 262
Estrogen receptor beta in breast cancer.
Palmieri, C., Cheng, G. J., Saji, S., Zelada-Hedman, M., W√§rri, A., Weihua, Z., Van Noorden, S., Wahlstrom, T., Coombes, R. C., Warner, M., et al. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090001 · Cited by 257
Linderholm, B., Grankvist, K., Wilking, N., Johansson, M., Tavelin, B., & Henriksson, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1423 · Cited by 254
Vindeløv, L. L., & Christensen, I. J. (1990) · Cytometry · doi:10.1002/cyto.990110702 · Cited by 248
Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., & Fernandez-Salguero, P. M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01296-0 · Cited by 234
Ruohola, J. K., Valve, E. M., Karkkainen, M. J., Joukov, V., Alitalo, K., & Härkönen, P. L. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00003-9 · Cited by 230
Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., Lakins, J., & Lupu, R. (2000) · Oncology Reports · doi:10.3892/or.7.1.157 · Cited by 197
Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
Basly, J.-P., Marre-Fournier, F., Le Bail, J.-C., Habrioux, G., & Chulia, A. J. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00650-5 · Cited by 179
Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
Fuqua, S. A. W., Schiff, R., Parra, I., Friedrichs, W. E., Su, J. L., McKee, D. D., Slentz‐Kesler, K., Moore, L. B., Willson, T. M., & Moore, J. T. (1999) · PubMed · Cited by 177
Fang, N., & Casida, J. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3380 · Cited by 177
Cheng, G., Weihua, Z., Mäkinen, S., Mäkelä, S., Saji, S., Warner, M., Gustafsson, J.-A., & Hovatta, O. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.1.77 · Cited by 170
Dabrosin, C., Chen, J., Wang, L., & Thompson, L. U. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00239-2 · Cited by 148
Self-citationNilsen, J., Mor, G., & Naftolin, F. N. (2000) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(200004)43:1<64::aid-neu6>3.0.co;2-7 · Cited by 144
Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin, S., & Dabrosin, C. (2003) · PubMed · Cited by 136
Self-citationEl‐Mowafy, A. M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg015 · Cited by 117
Obrero, M., Yu, D. V., & Shapiro, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208092200 · Cited by 116
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors and
Bowers, J. L. (2000) · Endocrinology · doi:10.1210/en.141.10.3657 · Cited by 111
Turner, R. T., Evans, G. L., Zhang, M., Maran, A., & Sibonga, J. D. (1999) · Endocrinology · doi:10.1210/endo.140.1.6460 · Cited by 105
Dabrosin, C., Margetts, P. J., & Gauldie, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11398 · Cited by 77
Self-citationDabrosin, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021584 · Cited by 66
Self-citationSchor, A. M., Pendleton, N., Pazouki, S., Smither, R. L., Morris, J., Lessan, K., Heerkens, E. H. J., Chandrachud, L. M., Carmichael, G., Adi, M. M., et al. (1998) · The Histochemical Journal · doi:10.1023/a:1003437619956 · Cited by 65
ZDOLSEK, J. M., Roberg, K. B., & Brunk, U. T. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90120-j · Cited by 65
Levenson, A. S., Svoboda, K. M., Pease, K. M., et al. (2002) · PubMed · Cited by 57
Is Resveratrol an Estrogen Agonist in Growing Rats?
Turner, R. T. (1999) · Endocrinology · doi:10.1210/en.140.1.50 · Cited by 54
Coradini, D., Pellizzaro, C., Speranza, A., & Daidone, M. G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3324-0 · Cited by 37
Cited by
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
Khan, N., Afaq, F., & Mukhtar, H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1740 · Cited by 591
Perspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Metadata
- Authors
- Garvin, S., Öllinger, K., & Dabrosin, C.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 231
- Issue
- 1
- Pages
- 113-122
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2035721941
- Cited by
- 351
- References
- 47
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.